CSLR vs. AIP, TGAN, VLN, CAN, GCTS, MX, QUIK, AXTI, MRAM, and ATOM
Should you be buying Complete Solaria stock or one of its competitors? The main competitors of Complete Solaria include Arteris (AIP), Transphorm (TGAN), Valens Semiconductor (VLN), Canaan (CAN), GCT Semiconductor (GCTS), Magnachip Semiconductor (MX), QuickLogic (QUIK), AXT (AXTI), Everspin Technologies (MRAM), and Atomera (ATOM). These companies are all part of the "semiconductors & related devices" industry.
Arteris (NASDAQ:AIP) and Complete Solaria (NASDAQ:CSLR) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, valuation, risk, earnings, profitability, institutional ownership, analyst recommendations and community ranking.
Complete Solaria has a net margin of 0.00% compared to Complete Solaria's net margin of -69.70%. Complete Solaria's return on equity of -198.35% beat Arteris' return on equity.
64.4% of Arteris shares are held by institutional investors. Comparatively, 30.3% of Complete Solaria shares are held by institutional investors. 33.7% of Arteris shares are held by insiders. Comparatively, 92.5% of Complete Solaria shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
In the previous week, Arteris had 1 more articles in the media than Complete Solaria. MarketBeat recorded 3 mentions for Arteris and 2 mentions for Complete Solaria. Complete Solaria's average media sentiment score of 1.39 beat Arteris' score of 0.58 indicating that Arteris is being referred to more favorably in the media.
Arteris has higher earnings, but lower revenue than Complete Solaria.
Arteris received 13 more outperform votes than Complete Solaria when rated by MarketBeat users. However, 100.00% of users gave Complete Solaria an outperform vote while only 57.69% of users gave Arteris an outperform vote.
Arteris presently has a consensus price target of $13.40, suggesting a potential upside of 64.01%. Complete Solaria has a consensus price target of $6.00, suggesting a potential upside of 242.86%. Given Arteris' stronger consensus rating and higher probable upside, analysts plainly believe Complete Solaria is more favorable than Arteris.
Arteris has a beta of 1.04, suggesting that its stock price is 4% more volatile than the S&P 500. Comparatively, Complete Solaria has a beta of 0.03, suggesting that its stock price is 97% less volatile than the S&P 500.
Summary
Arteris beats Complete Solaria on 10 of the 16 factors compared between the two stocks.
Get Complete Solaria News Delivered to You Automatically
Sign up to receive the latest news and ratings for CSLR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CSLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Complete Solaria Competitors List
Related Companies and Tools
